Cuifu Yu

406 total citations
15 papers, 300 citations indexed

About

Cuifu Yu is a scholar working on Molecular Biology, Cancer Research and Cell Biology. According to data from OpenAlex, Cuifu Yu has authored 15 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Cell Biology. Recurrent topics in Cuifu Yu's work include Ubiquitin and proteasome pathways (10 papers), Protein Degradation and Inhibitors (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Cuifu Yu is often cited by papers focused on Ubiquitin and proteasome pathways (10 papers), Protein Degradation and Inhibitors (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Cuifu Yu collaborates with scholars based in China and United States. Cuifu Yu's co-authors include Hongbiao Huang, Xiaohong Xia, Yuning Liao, Zhenlong Shao, Jinchan He, Yuan Liu, Qiong Xu, Jinbao Liu, Ningning Liu and Daolin Tang and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Experimental Cell Research.

In The Last Decade

Cuifu Yu

15 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cuifu Yu China	12	238	91	58	43	38	15	300
Jinchan He China	9	295 1.2×	108 1.2×	62 1.1×	44 1.0×	33 0.9×	10	352
Quyen Thu Bui South Korea	7	190 0.8×	93 1.0×	60 1.0×	40 0.9×	37 1.0×	11	279
Zhenlong Shao China	11	300 1.3×	130 1.4×	53 0.9×	60 1.4×	46 1.2×	16	363
Ulrike Heinicke Germany	12	297 1.2×	79 0.9×	57 1.0×	48 1.1×	19 0.5×	20	405
Raie Bekele United States	7	218 0.9×	69 0.8×	44 0.8×	33 0.8×	58 1.5×	11	307
Lokman Varışlı Türkiye	11	261 1.1×	94 1.0×	100 1.7×	88 2.0×	43 1.1×	28	410
Sha Du China	11	219 0.9×	96 1.1×	117 2.0×	75 1.7×	54 1.4×	18	354
Xavier Bernard United States	4	238 1.0×	90 1.0×	42 0.7×	49 1.1×	27 0.7×	4	328
Tuya Bai Japan	12	318 1.3×	108 1.2×	100 1.7×	53 1.2×	49 1.3×	21	409
Jiun‐Han Lin Taiwan	7	244 1.0×	125 1.4×	113 1.9×	78 1.8×	40 1.1×	8	372

Countries citing papers authored by Cuifu Yu

Since Specialization

Citations

This map shows the geographic impact of Cuifu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cuifu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cuifu Yu more than expected).

Fields of papers citing papers by Cuifu Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cuifu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cuifu Yu. The network helps show where Cuifu Yu may publish in the future.

Co-authorship network of co-authors of Cuifu Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Cuifu Yu. A scholar is included among the top collaborators of Cuifu Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cuifu Yu. Cuifu Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zhao, Ruijun, Yuting Li, Cuifu Yu, et al.. (2024). Ku70 targets BRD3-MYC/Cyclin D1 axis to drive hepatocellular carcinoma progression. Experimental Cell Research. 444(2). 114404–114404. 1 indexed citations

Liao, Yuning, Yuan Liu, Cuifu Yu, et al.. (2023). HSP90β Impedes STUB1‐Induced Ubiquitination of YTHDF2 to Drive Sorafenib Resistance in Hepatocellular Carcinoma. Advanced Science. 10(27). e2302025–e2302025. 21 indexed citations

Liu, Yuan, Cuifu Yu, Zhenlong Shao, et al.. (2022). SNS-023 sensitizes hepatocellular carcinoma to sorafenib by inducing degradation of cancer drivers SIX1 and RPS16. Acta Pharmacologica Sinica. 44(4). 853–864. 20 indexed citations

Yu, Cuifu, et al.. (2022). ARV-771 Acts as an Inducer of Cell Cycle Arrest and Apoptosis to Suppress Hepatocellular Carcinoma Progression. Frontiers in Pharmacology. 13. 858901–858901. 11 indexed citations

Xia, Xiaohong, Yuan Liu, Cuifu Yu, et al.. (2022). Neddylation of HER2 Inhibits its Protein Degradation and promotes Breast Cancer Progression. International Journal of Biological Sciences. 19(2). 377–392. 14 indexed citations

Xia, Xiaohong, Xiaolin Liu, Renjie Chai, et al.. (2021). USP10 exacerbates neointima formation by stabilizing Skp2 protein in vascular smooth muscle cells. Journal of Biological Chemistry. 297(5). 101258–101258. 12 indexed citations

Xia, Xiaohong, Chuyi Huang, Yuning Liao, et al.. (2021). The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression. Cell Death and Disease. 12(4). 329–329. 31 indexed citations

Liao, Yuning, Zhenlong Shao, Yuan Liu, et al.. (2021). USP1-dependent RPS16 protein stability drives growth and metastasis of human hepatocellular carcinoma cells. Journal of Experimental & Clinical Cancer Research. 40(1). 201–201. 39 indexed citations

Liu, Yuan, Cuifu Yu, Zhenlong Shao, et al.. (2021). Selective degradation of AR-V7 to overcome castration resistance of prostate cancer. Cell Death and Disease. 12(10). 857–857. 34 indexed citations

10.

Liao, Yuning, Yuan Liu, Zhenlong Shao, et al.. (2021). A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance. Oncogene. 40(25). 4291–4306. 31 indexed citations

11.

Liu, Yuan, Zhenlong Shao, Yuning Liao, et al.. (2020). Targeting SKP2/Bcr-Abl pathway with Diosmetin suppresses chronic myeloid leukemia proliferation. European Journal of Pharmacology. 883. 173366–173366. 16 indexed citations

12.

Xia, Xiaohong, Jinchan He, Qiong Xu, et al.. (2020). USP10 deletion inhibits macrophage-derived foam cell formation and cellular-oxidized low density lipoprotein uptake by promoting the degradation of CD36. Aging. 12(22). 22892–22905. 15 indexed citations

13.

Xia, Xiaohong, Qiong Xu, Mingke Liu, et al.. (2020). Deubiquitination of CD36 by UCHL1 promotes foam cell formation. Cell Death and Disease. 11(8). 636–636. 37 indexed citations

14.

Xia, Xiaohong, Jinchan He, Bin Liu, et al.. (2020). Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment. International Journal of Biological Sciences. 16(12). 2192–2204. 11 indexed citations

15.

Huang, Chuyi, Xiaohong Xia, Jinchan He, et al.. (2020). ERα is a target for butein-induced growth suppression in breast cancer.. PubMed. 10(11). 3721–3736. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact